Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts

J. Espin; M. Schlander; B. Godman; P. Anderson; J. Mestre-Ferrandiz; A. Hutchings; S. Flostrand; A. Parnaby

Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts

J. Espin, M. Schlander, B. Godman, P. Anderson, J. Mestre-Ferrandiz, A. Hutchings, S. Flostrand, A. Parnaby

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to conference › Abstract › peer-review

36 Downloads (Pure)

Abstract

European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.

Original language	English
Number of pages	1
Publication status	Accepted/In press - 7 Aug 2017
Event	ISPOR 20th Annual European Congress - Glasgow, United Kingdom Duration: 4 Nov 2017 → 8 Nov 2017 Conference number: 20th https://www.ispor.org/Event/index/2017Glasgow

Conference

Conference	ISPOR 20th Annual European Congress
Country/Territory	United Kingdom
City	Glasgow
Period	4/11/17 → 8/11/17
Internet address	https://www.ispor.org/Event/index/2017Glasgow

Keywords

European healthcare
healthcare expenditure
pharmacoeconomics

Access to Document

Espin-etal-ISPOR-2017-Forecasting-pharmaceutical-expenditure-in-Europe-adjusting-for-the-impactAccepted author manuscript, 128 KB

Cite this

@conference{4f95e10b7ea346be88e6024eaaf0e1c9,

title = "Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts",

abstract = "European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.",

keywords = "European healthcare, healthcare expenditure, pharmacoeconomics",

author = "J. Espin and M. Schlander and B. Godman and P. Anderson and J. Mestre-Ferrandiz and A. Hutchings and S. Flostrand and A. Parnaby",

year = "2017",

month = aug,

day = "7",

language = "English",

note = "ISPOR 20th Annual European Congress ; Conference date: 04-11-2017 Through 08-11-2017",

url = "https://www.ispor.org/Event/index/2017Glasgow",

}

Forecasting pharmaceutical expenditure in Europe : adjusting for the impact of rebates and discounts. / Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Hutchings, A.; Flostrand, S.; Parnaby, A.

2017. Abstract from ISPOR 20th Annual European Congress, Glasgow, United Kingdom.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Forecasting pharmaceutical expenditure in Europe

T2 - ISPOR 20th Annual European Congress

AU - Espin, J.

AU - Schlander, M.

AU - Godman, B.

AU - Anderson, P.

AU - Mestre-Ferrandiz, J.

AU - Hutchings, A.

AU - Flostrand, S.

AU - Parnaby, A.

N1 - Conference code: 20th

PY - 2017/8/7

Y1 - 2017/8/7

N2 - European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.

AB - European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.

KW - European healthcare

KW - healthcare expenditure

KW - pharmacoeconomics

UR - https://www.ispor.org/Event/index/2017Glasgow

M3 - Abstract

Y2 - 4 November 2017 through 8 November 2017

ER -

Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts

Abstract

Conference

Keywords

Access to Document

Other files and links

Fingerprint

Cite this